<DOC>
	<DOCNO>NCT02408146</DOCNO>
	<brief_summary>The investigator hypothesize use new intravenous infusion pump patient-controlled analgesia ( parecoxib sodium 1 mg/mL + normal saline ) would significantly improve postoperative pain control compare conventional intravenous infusion pump patient-controlled analgesia ( fentanyl citrate 20 mg/mL/kg + ondansetron hydrochloride 16 mg/8 mL + normal saline ) . This prospective randomized control trial design evaluate benefit new intravenous infusion pump patient-controlled analgesia ( parecoxib sodium 1 mg/mL + normal saline ) postoperative analgesia laparotomic liver resection .</brief_summary>
	<brief_title>The Effect Parecoxib Sodium Intravenous Patient-controlled Analgesia Laparotomic Liver Resection</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Fentanyl</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<mesh_term>Parecoxib</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Patients need laparotomic liver resection . Patients contraindication spinal anesthesia intrathecal morphine , difficulty understand passive cutaneous anaphylaxis , history drug dependence chronic pain , body mass index great 35 kg/m2 , history sleep apnea exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>